Expanded Access Policy

Expanded Access is the use of an investigational drug outside of a clinical trial. Currently, Calico does not offer an Expanded Access program; participation in our clinical trials is the only way for patients to gain access to Calico’s investigational drugs. As more data on the safety and efficacy of our investigational drugs become available, we will review and update our policy on Expanded Access.